Ozempic Among the Next Drugs Up for Medicare Price Negotiations

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

CNBC - 5h

Ozempic picked for Medicare price bargaining

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...

The Hill - 6h

Obesity drugs Ozempic and Wegovy included in US price-cut talks

Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiations

Financial Times - 7h

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

The Wall Street Journal - 13h

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

The New York Times - 15h

Biden to Commute Drug Offender Sentences

The action, aimed at inmates who received harsher sentences based on old disparities in drug laws, is the broadest commutation of individual sentences ever issued by a U.S. president.

The New York Times - 7h

The next 15 drugs chosen for Medicare negotiation

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...

The Hill - 13h

White House says popular weight-loss drug Ozempic subject to Medicare talks

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

MarketWatch - 14h

Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

NBC News - 14h

Ozempic, Wegovy on list for Medicare drug price negotiations

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

CBS News - 14h

CMS to seek Medicare negotiations on Ozempic price

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...

The Hill - 15h

Biden administration picks 15 more drugs for Medicare negotiation

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...

The Hill - 16h

UPS could help end the ‘freight recession’ this year. It may have to raise prices first.

Analysts say deregulation, lower taxes under Trump could spur small-business investments and more shipments — but tariffs could weigh down volumes.

MarketWatch - 1d

How Roki Sasaki finalists can get a leg up in contract negotiations for Japanese ace

Sasaki has reportedly narrowed his suitors down to three teams

CBS Sports - 1d

Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.

CNBC - 1d

Amazon’s Next-Gen Alexa Held Up By Technical Glitches

The e-commerce and streaming giant used to have the most widely used voice-activated AI before the ChatGPT revolution, but recent company comments suggest it may be a victim of its early success.

Inc. - 2d

Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.

NBC News - 3d

AO live blog: Fritz advances, Medvedev up next on Day 3

A host of stars are set to grace the courts at Melbourne Park for the third and final day of Round 1 action.

ESPN - 4d

GSK to buy US cancer drug firm IDRx for up to $1.15bn

Massachusetts-based company is working on new treatments for gastrointestinal cancers. Business live – latest updates GSK has struck a deal worth up to $1.15bn (£950m) to acquire a ...

The Guardian - 4d

The King of Ozempic Is Scared as Hell

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Wired - 4d

This Rule Helps You Never Negotiate Against Yourself

How to maintain your leverage during negotiations.

Inc. - 5d

New York City's congestion pricing picks up speed

The first congestion pricing plan in the U.S. has begun, charging most drivers $9 a day to enter the lower half of Manhattan. The long-debated plan is projected to raise up to $800 million a year ...

CBS News - 5d

Baby boomers and ‘Ozempic face’ drive injectables craze

People ‘want to look what they feel like, not what they may look like’ says dermatology giant Galderma

Financial Times - 6d

Drafting Chase Brown, picking up Jonnu Smith among best moves of 2024

No matter how well your team did, there's at least one decision that you're proud of. Our staff recounts theirs.

ESPN - Jan. 10

Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds

AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.

CNBC - Jan. 9

How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.

The New York Times - Jan. 9

Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

NBC News - Jan. 9

Senate approves committee assignments, tees up confirmation hearings next week

The Senate on Tuesday approved its organizing resolution for the 119th Congress, officially setting the composition of committees and greenlighting nomination hearings to take place in the coming ...

The Hill - Jan. 7

The Next Congress

We explore the disagreements that could define the new Congress — and potentially derail Donald Trump’s agenda.

The New York Times - Jan. 7

Ketamine could be reclassified as Class A drug

Illegal use of the drug reached record levels last year, the Home Office said.

BBC News - Jan. 7

Next blames clothes price rises on wage increases set out in Budget

The retailer expects employee costs to increase by £73m due in part to rising National Insurance

BBC News - Jan. 7

Next Ups Guidance After Strong Christmas

Next lifted its fiscal-year outlook after Christmas sales were better than expected but said U.K. growth is likely to slow, as higher employer tax costs begin to filter through into the economy.

The Wall Street Journal - Jan. 7

Eager for what's 'Next,' Xavi opens up about his rise to the top

With the release his debut album, 'Next,' up-and-comer Xavi shares a robust look into his world of "música Mexicana fusions." The 20-year-old singer-songwriter of 'La Diabla' fame dishes on his ...

Los Angeles Times - Jan. 6